CScape-somatic

CScape-somatic predicts whether somatic single nucleotide variants (SNVs) in coding and non-coding regions are recurrent (potential drivers) or rare (likely passengers) using somatic mutation data from cancer genomes to support interpretation of next-generation sequencing (NGS)-derived cancer genomic data.

Key Features:

• Predictive Classification: An integrative classifier predicts recurrence versus rarity of somatic SNVs across coding and non-coding regions of the human cancer genome.
• Data-Driven Approach: Uses exclusively somatic mutation data from cancer genomes rather than benign germline variants (e.g., from the 1000 Genomes Project) to reduce germline–somatic bias.
• Performance Metrics: Reports balanced accuracy of 74% for coding regions and 69% for non-coding regions for mutation classification.
• High-Confidence Predictions: Applies specific score thresholds to isolate high-confidence recurrent or rare mutation predictions for downstream analysis.

Scientific Applications:

• Driver versus Passenger Discrimination: Differentiates recurrent (potential driver) from rare (likely passenger) somatic point mutations in cancer genomes.
• Tumor Heterogeneity Analysis: Supports examination of mutation recurrence patterns that inform tumor heterogeneity studies.
• Therapeutic Target Identification: Aids identification of recurrent mutations that may serve as candidate targets for developing targeted therapies.
• Personalized Medicine Support: Provides mutation-level recurrence information useful for precision oncology and individualized genomic interpretation.

Methodology:

Analyzes somatic point mutations from cancer genome data using an integrative classifier that distinguishes minimal occurrence from significantly recurrent mutations and applies thresholds to produce high-confidence predictions.